Table 3.

Treatment use during variable-length follow-up period – incidence rates^*

Treatments	Oncology cohort (n = 1590)			Urology cohort (n = 995)			Oncology vs urology cohort
	Events	Person-time	Rate	Events	Person-time	Rate	Ratio	P-value
Hormones	1199	2381	50.36	608	1542	39.42	1.28	<0.001
Chemotherapy	745	2381	31.29	101	1542	6.55	4.78	<0.001
Radiation	679	2381	28.52	97	1542	6.29	4.53	<0.001
Other medications	1334	2381	56.03	627	1542	40.66	1.38	<0.001

Note:

^*Incidence per 100 person-years.